The biosimilar development market is becoming increasingly competitive, putting first-to-market biopharmaceutical companies at a key advantage. Discover how to de-risk the launch process by choosing a suitable autoinjector technology and partner.
In this interview, experts discuss the benefits of using integrated systems for sophisticated drug device combination products with multiple device subsystems, and the crucial role a partner can play as a systems integrator.
Developing an effective drug-device combination product for self-administered biologics is complex. A well-executed strategy will help support integration with manufacturing operations and successful drug delivery.
